IRBESARTAN

IRBESARTAN was reported 45098 times

IRBESARTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 65 0.9286
1 NEUROLOGIC NEGLECT SYNDROME 295 0.5306
2 RADIATION INFLAMMATION 39 0.4875
3 CAROTID ARTERY THROMBOSIS 306 0.3604
4 HEART FAILURE WITH PRESERVED EJECTION FRACTION 81 0.2755
5 ADJUSTMENT DISORDER 294 0.2262
6 CENTRAL NERVOUS SYSTEM LUPUS 47 0.2108
7 BODY MASS INDEX ABNORMAL 46 0.1885
8 GASTROINTESTINAL PROCEDURAL COMPLICATION 35 0.1306
9 PERSONALITY DISORDER 306 0.1167
10 SEROSITIS 48 0.0868
11 BLOOD PRESSURE SYSTOLIC ABNORMAL 165 0.0667
12 BLOOD PRESSURE DIASTOLIC ABNORMAL 153 0.0601
13 PULMONARY PAIN 130 0.0445
14 HEMIPLEGIA 340 0.0408
15 SENSORY LOSS 329 0.0408
16 SERONEGATIVE ARTHRITIS 41 0.0358
17 GANGRENE 201 0.0333
18 LEFT ATRIAL DILATATION 42 0.0329
19 AFFECT LABILITY 314 0.0326
20 MOTOR DYSFUNCTION 317 0.0311
21 CAROTID ARTERIOSCLEROSIS 30 0.0291
22 ARTERIAL OCCLUSIVE DISEASE 228 0.0290
23 MUSCLE SPASTICITY 343 0.0279
24 LUPUS NEPHRITIS 52 0.0278
25 HAEMATOMA MUSCLE 30 0.0250
26 BLOOD PRESSURE SYSTOLIC INCREASED 487 0.0249
27 COORDINATION ABNORMAL 333 0.0238
28 TACHYARRHYTHMIA 59 0.0236
29 HYPERPARATHYROIDISM SECONDARY 58 0.0231
30 WRONG PATIENT RECEIVED PRODUCT 66 0.0225
31 HEMIPARESIS 381 0.0225
32 CONDUCTION DISORDER 39 0.0213
33 BLOOD PRESSURE DIASTOLIC DECREASED 151 0.0204
34 BLOOD PRESSURE INADEQUATELY CONTROLLED 123 0.0204
35 HYPERKALAEMIA 709 0.0202
36 SINUS CONGESTION 270 0.0200
37 NEPHROGENIC ANAEMIA 92 0.0198
38 LIPOMA 50 0.0193
39 BUNDLE BRANCH BLOCK LEFT 77 0.0181
40 HYPERLACTACIDAEMIA 48 0.0179
41 HYPONATRAEMIA 980 0.0174
42 EATING DISORDER 352 0.0165
43 INFLAMMATORY MARKER INCREASED 81 0.0163
44 SKIN HAEMORRHAGE 242 0.0163
45 BLOOD IMMUNOGLOBULIN E INCREASED 39 0.0161
46 ATRIOVENTRICULAR BLOCK FIRST DEGREE 68 0.0157
47 RESPIRATORY TRACT CONGESTION 248 0.0156
48 INTRAVENTRICULAR HAEMORRHAGE 37 0.0149
49 RASH MORBILLIFORM 41 0.0148
50 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 150 0.0146
51 PEMPHIGOID 110 0.0146
52 RENAL CYST 115 0.0145
53 LACTIC ACIDOSIS 468 0.0144
54 ACUTE KIDNEY INJURY 2187 0.0143
55 BODY TEMPERATURE DECREASED 140 0.0142
56 HYPOVOLAEMIA 83 0.0142
57 MIXED LIVER INJURY 42 0.0139
58 RENAL FAILURE CHRONIC 107 0.0139
59 KERATITIS 42 0.0138
60 HYPOMAGNESAEMIA 192 0.0138
61 AORTIC STENOSIS 47 0.0135
62 RHINALGIA 37 0.0134
63 ANGINA PECTORIS 385 0.0134
64 SUPRAVENTRICULAR EXTRASYSTOLES 45 0.0133
65 SINUS DISORDER 263 0.0133
66 APHASIA 397 0.0131
67 RALES 76 0.0131
68 VENTRICULAR HYPOKINESIA 42 0.0131
69 SNEEZING 292 0.0130
70 GRANULOMA 45 0.0130
71 BLOOD PRESSURE FLUCTUATION 312 0.0130
72 ANGIONEUROTIC OEDEMA 34 0.0127
73 BLOOD PRESSURE DIASTOLIC INCREASED 58 0.0126
74 REBOUND ACID HYPERSECRETION 38 0.0125
75 ANURIA 108 0.0125
76 PARANASAL SINUS DISCOMFORT 46 0.0121
77 COLITIS MICROSCOPIC 57 0.0120
78 PANCREATIC CARCINOMA METASTATIC 34 0.0119
79 OESOPHAGEAL PAIN 47 0.0119
80 DYSLIPIDAEMIA 60 0.0118
81 ATRIOVENTRICULAR BLOCK COMPLETE 79 0.0118
82 CYTOLYTIC HEPATITIS 39 0.0117
83 GOITRE 48 0.0117
84 SINUS BRADYCARDIA 113 0.0117
85 POTENTIATING DRUG INTERACTION 39 0.0116
86 AORTIC VALVE INCOMPETENCE 49 0.0115
87 HEPATIC CYTOLYSIS 146 0.0114
88 OLIGURIA 71 0.0114
89 CYSTITIS 361 0.0113
90 POLYMYALGIA RHEUMATICA 36 0.0113
91 DIABETIC NEUROPATHY 56 0.0113
92 DIVERTICULUM INTESTINAL 49 0.0112
93 ATRIAL FLUTTER 89 0.0111
94 DYSARTHRIA 419 0.0111
95 BLOOD SODIUM INCREASED 30 0.0111
96 OBESITY 176 0.0110
97 ISCHAEMIC STROKE 195 0.0109
98 ACUTE PULMONARY OEDEMA 61 0.0109
99 HEART VALVE INCOMPETENCE 31 0.0108
100 RENAL FAILURE ACUTE 459 0.0108
101 CHOLESTASIS 206 0.0107
102 ORTHOPNOEA 34 0.0107
103 MITRAL VALVE INCOMPETENCE 120 0.0106
104 CAROTID ARTERY STENOSIS 37 0.0106
105 SHOCK HAEMORRHAGIC 86 0.0106
106 LOSS OF CONTROL OF LEGS 40 0.0105
107 THERAPEUTIC AGENT TOXICITY 35 0.0105
108 BUNDLE BRANCH BLOCK RIGHT 48 0.0104
109 HYPERTENSIVE CRISIS 116 0.0104
110 CHRONIC SINUSITIS 39 0.0104
111 BLOOD PRESSURE SYSTOLIC DECREASED 46 0.0101
112 BLOOD PRESSURE INCREASED 1537 0.0100
113 EOSINOPHILIA 174 0.0099
114 CEREBRAL HAEMATOMA 33 0.0098
115 ORTHOSTATIC HYPOTENSION 171 0.0098
116 ARTERIOSCLEROSIS CORONARY ARTERY 65 0.0098
117 ISCHAEMIC CARDIOMYOPATHY 30 0.0098
118 HEART RATE DECREASED 341 0.0097
119 LEFT VENTRICULAR HYPERTROPHY 41 0.0096
120 TRIGGER FINGER 39 0.0095
121 TRICUSPID VALVE INCOMPETENCE 75 0.0094
122 HAEMOGLOBIN INCREASED 43 0.0094
123 GOUT 169 0.0094
124 DERMATITIS EXFOLIATIVE 47 0.0094
125 GASTROINTESTINAL MOTILITY DISORDER 50 0.0093
126 END STAGE RENAL DISEASE 170 0.0093
127 BRADYCARDIA 492 0.0093
128 HEPATOCELLULAR INJURY 131 0.0092
129 ANORECTAL DISCOMFORT 49 0.0092
130 SPINAL STENOSIS 38 0.0092
131 BLOOD MAGNESIUM DECREASED 79 0.0091
132 IRON DEFICIENCY 41 0.0091
133 RESPIRATORY RATE INCREASED 80 0.0090
134 ANGINA UNSTABLE 58 0.0089
135 SPINAL OSTEOARTHRITIS 78 0.0089
136 TUBULOINTERSTITIAL NEPHRITIS 166 0.0088
137 BRONCHIOLITIS 31 0.0088
138 RHINORRHOEA 567 0.0088
139 CUTANEOUS VASCULITIS 32 0.0088
140 RENAL TUBULAR NECROSIS 84 0.0086
141 CARDIOMEGALY 105 0.0085
142 EUGLYCAEMIC DIABETIC KETOACIDOSIS 35 0.0085
143 ECCHYMOSIS 58 0.0085
144 EXTRASYSTOLES 59 0.0084
145 CARDIAC FAILURE CHRONIC 36 0.0084
146 DIVERTICULUM 60 0.0084
147 ELECTROLYTE IMBALANCE 98 0.0084
148 HYPOGLYCAEMIA 409 0.0084
149 RHABDOMYOLYSIS 351 0.0084
150 BLOOD SODIUM DECREASED 158 0.0084
151 OBSTRUCTIVE AIRWAYS DISORDER 93 0.0084
152 URINE OUTPUT DECREASED 73 0.0083
153 SPUTUM DISCOLOURED 79 0.0083
154 BLOOD POTASSIUM INCREASED 135 0.0083
155 AORTIC ANEURYSM 63 0.0083
156 ATELECTASIS 80 0.0083
157 LOCALISED OEDEMA 38 0.0082
158 ACUTE CORONARY SYNDROME 68 0.0082
159 AGRANULOCYTOSIS 152 0.0082
160 HYPOKALAEMIA 377 0.0082
161 ERYSIPELAS 41 0.0082
162 TORSADE DE POINTES 64 0.0081
163 TROPONIN INCREASED 62 0.0081
164 LYMPHOEDEMA 56 0.0081
165 VULVOVAGINAL PRURITUS 41 0.0081
166 GRIP STRENGTH DECREASED 71 0.0081
167 MUSCLE STRAIN 69 0.0080
168 RED CELL DISTRIBUTION WIDTH INCREASED 33 0.0079
169 ATRIAL FIBRILLATION 770 0.0079
170 NEPHROTIC SYNDROME 54 0.0079
171 CORONARY ARTERY DISEASE 236 0.0078
172 CATARACT 463 0.0078
173 DYSPNOEA EXERTIONAL 289 0.0077
174 PANCREATITIS ACUTE 172 0.0076
175 SYNOVIAL CYST 35 0.0076
176 MYOSITIS 68 0.0076
177 RENAL IMPAIRMENT 636 0.0076
178 DRUG INTERACTION 1191 0.0075
179 HYPOTENSION 1501 0.0075
180 PROTEINURIA 142 0.0075
181 OXYGEN SATURATION DECREASED 416 0.0074
182 BLOOD CREATININE INCREASED 478 0.0073
183 HYPERURICAEMIA 30 0.0073
184 MYOCARDIAL ISCHAEMIA 83 0.0073
185 URINE ABNORMALITY 33 0.0073
186 ATRIOVENTRICULAR BLOCK 56 0.0072
187 GLOMERULAR FILTRATION RATE DECREASED 89 0.0072
188 LOWER RESPIRATORY TRACT INFECTION 329 0.0072
189 RASH MACULO-PAPULAR 160 0.0072
190 SHOCK 165 0.0072
191 KNEE ARTHROPLASTY 151 0.0072
192 INTERNATIONAL NORMALISED RATIO INCREASED 203 0.0071
193 RED BLOOD CELL SEDIMENTATION RATE INCREASED 78 0.0070
194 BLOOD CREATINE INCREASED 31 0.0070
195 HIATUS HERNIA 90 0.0069
196 RENAL FAILURE 920 0.0069
197 FOOD POISONING 37 0.0069
198 ANAL FISSURE 37 0.0069
199 SKIN LACERATION 75 0.0069
200 C-REACTIVE PROTEIN ABNORMAL 44 0.0069
201 HAEMATURIA 234 0.0068
202 MYOPATHY 59 0.0068
203 CHRONIC KIDNEY DISEASE 519 0.0068
204 MUSCULAR WEAKNESS 774 0.0068
205 PYELONEPHRITIS 59 0.0068
206 BLOOD UREA INCREASED 114 0.0068
207 PERIPHERAL VASCULAR DISORDER 35 0.0068
208 DERMATITIS BULLOUS 49 0.0068
209 CHEST DISCOMFORT 690 0.0067
210 LEFT VENTRICULAR DYSFUNCTION 45 0.0067
211 GASTROENTERITIS 98 0.0067
212 BLOOD URINE PRESENT 127 0.0067
213 HAEMORRHAGIC STROKE 52 0.0067
214 POISONING DELIBERATE 63 0.0066
215 HEART RATE IRREGULAR 149 0.0066
216 CORONARY ARTERY STENOSIS 33 0.0066
217 TOXIC SKIN ERUPTION 66 0.0065
218 NASAL DRYNESS 41 0.0065
219 NEPHROPATHY 61 0.0065
220 HYPERKERATOSIS 36 0.0065
221 METABOLIC ACIDOSIS 208 0.0065
222 IRON DEFICIENCY ANAEMIA 60 0.0065
223 SUBDURAL HAEMATOMA 93 0.0065
224 TYPE 1 DIABETES MELLITUS 39 0.0065
225 ARTHRITIS INFECTIVE 30 0.0065
226 PHLEBITIS 33 0.0064
227 PULMONARY MASS 96 0.0064
228 UROSEPSIS 59 0.0064
229 MUSCULOSKELETAL DISCOMFORT 110 0.0064
230 PROSTATIC SPECIFIC ANTIGEN INCREASED 88 0.0064
231 CARDIAC MURMUR 55 0.0064
232 VENTRICULAR EXTRASYSTOLES 66 0.0063
233 SKIN ABRASION 30 0.0063
234 GASTRITIS 167 0.0063
235 DIABETES MELLITUS INADEQUATE CONTROL 112 0.0063
236 APHTHOUS ULCER 49 0.0063
237 UPPER GASTROINTESTINAL HAEMORRHAGE 106 0.0063
238 OEDEMA PERIPHERAL 768 0.0063
239 ARTERIOSCLEROSIS 59 0.0063
240 EXERCISE TOLERANCE DECREASED 36 0.0062
241 SYNCOPE 625 0.0062
242 HYPERTENSION 1322 0.0062
243 BLOOD IRON DECREASED 74 0.0062
244 HYPERCALCAEMIA 77 0.0062
245 PROCTALGIA 40 0.0062
246 HAEMODIALYSIS 52 0.0062
247 GASTROINTESTINAL PAIN 68 0.0062
248 ADRENAL INSUFFICIENCY 75 0.0062
249 PRESYNCOPE 150 0.0062
250 FALL 2038 0.0061
251 ACUTE MYOCARDIAL INFARCTION 180 0.0061
252 LARGE INTESTINE POLYP 42 0.0061
253 VULVOVAGINAL BURNING SENSATION 37 0.0061
254 BLOOD URIC ACID INCREASED 35 0.0061
255 BLOOD ALBUMIN DECREASED 48 0.0060
256 SUDDEN DEATH 64 0.0060
257 BLOOD CREATINE PHOSPHOKINASE INCREASED 174 0.0060
258 DYSPHAGIA 568 0.0060
259 SQUAMOUS CELL CARCINOMA OF SKIN 36 0.0060
260 ENTERITIS 38 0.0059
261 NOCTURIA 72 0.0059
262 OSTEOARTHRITIS 251 0.0059
263 ARTHROPATHY 329 0.0059
264 PRODUCTIVE COUGH 282 0.0059
265 MELAENA 130 0.0059
266 RENAL PAIN 62 0.0058
267 CONFUSIONAL STATE 941 0.0058
268 LIMB INJURY 158 0.0058
269 PALPITATIONS 681 0.0058
270 ANGIOEDEMA 256 0.0058
271 CARDIOGENIC SHOCK 83 0.0058
272 CARDIAC VALVE DISEASE 33 0.0058
273 LIPASE INCREASED 44 0.0057
274 BLOOD PRESSURE ABNORMAL 114 0.0057
275 ARTHRITIS 451 0.0057
276 ARRHYTHMIA 271 0.0057
277 SLEEP APNOEA SYNDROME 109 0.0057
278 HAEMORRHOIDS 111 0.0057
279 HYPERLIPIDAEMIA 68 0.0057
280 DUODENAL ULCER 40 0.0057
281 ANOREXIA 73 0.0057
282 DYSURIA 208 0.0056
283 ACIDOSIS 43 0.0056
284 RECTAL HAEMORRHAGE 241 0.0056
285 ROTATOR CUFF SYNDROME 72 0.0056
286 DEHYDRATION 743 0.0056
287 CLOSTRIDIUM DIFFICILE COLITIS 59 0.0056
288 BASAL CELL CARCINOMA 86 0.0055
289 HAEMATOCRIT DECREASED 109 0.0055
290 HYPOCALCAEMIA 104 0.0055
291 HEPATITIS 140 0.0055
292 INFLUENZA 609 0.0055
293 JAUNDICE 146 0.0054
294 DEFAECATION URGENCY 38 0.0054
295 GASTRIC ULCER 103 0.0054
296 COUGH 1519 0.0054
297 TOOTH ABSCESS 55 0.0054
298 SUBARACHNOID HAEMORRHAGE 55 0.0054
299 WHEEZING 319 0.0054
300 PHOTOPSIA 34 0.0054
301 ELECTROCARDIOGRAM QT PROLONGED 193 0.0054
302 BLOOD PRESSURE DECREASED 355 0.0053
303 BLOOD POTASSIUM DECREASED 160 0.0053
304 JOINT DISLOCATION 56 0.0053
305 CARDIAC FLUTTER 34 0.0053
306 DIZZINESS POSTURAL 51 0.0053
307 SINUSITIS 538 0.0052
308 VISUAL DISTURBANCE 30 0.0052
309 FAECES SOFT 38 0.0052
310 VENTRICULAR FIBRILLATION 58 0.0052
311 PLATELET COUNT INCREASED 68 0.0052
312 BRONCHIECTASIS 35 0.0052
313 SKIN INFECTION 58 0.0052
314 HYPERGLYCAEMIA 188 0.0052
315 SEASONAL ALLERGY 73 0.0052
316 WALKING AID USER 34 0.0052
317 CEREBROVASCULAR ACCIDENT 872 0.0051
318 HYPOALBUMINAEMIA 40 0.0051
319 BODY HEIGHT DECREASED 55 0.0051
320 CARDIO-RESPIRATORY ARREST 215 0.0051
321 POLYURIA 42 0.0051
322 FLANK PAIN 48 0.0051
323 DRY THROAT 52 0.0051
324 HYPERTHERMIA 39 0.0051
325 SQUAMOUS CELL CARCINOMA 48 0.0051
326 PURPURA 45 0.0051
327 CARDIAC FAILURE CONGESTIVE 407 0.0051
328 VASCULITIS 59 0.0051
329 GAMMA-GLUTAMYLTRANSFERASE INCREASED 112 0.0050
330 DYSGEUSIA 374 0.0050
331 TACHYPNOEA 68 0.0050
332 SALIVARY HYPERSECRETION 50 0.0050
333 OROPHARYNGEAL DISCOMFORT 45 0.0050
334 UPPER-AIRWAY COUGH SYNDROME 41 0.0050
335 INTERVERTEBRAL DISC DEGENERATION 46 0.0050
336 CORONARY ARTERY OCCLUSION 68 0.0050
337 HYDRONEPHROSIS 37 0.0049
338 GASTROINTESTINAL DISORDER 442 0.0049
339 CIRCULATORY COLLAPSE 84 0.0049
340 JOINT EFFUSION 34 0.0049
341 RECALLED PRODUCT ADMINISTERED 47 0.0049
342 CELLULITIS 248 0.0049
343 URINARY RETENTION 164 0.0049
344 MUSCULOSKELETAL CHEST PAIN 76 0.0049
345 EJECTION FRACTION DECREASED 76 0.0049
346 HAEMATOCHEZIA 269 0.0049
347 PULMONARY CONGESTION 64 0.0048
348 POOR VENOUS ACCESS 50 0.0048
349 THROMBOTIC MICROANGIOPATHY 47 0.0048
350 POLLAKIURIA 201 0.0048
351 LYMPHOPENIA 68 0.0048
352 DECUBITUS ULCER 39 0.0048
353 BRONCHITIS 354 0.0048
354 RENAL INJURY 142 0.0048
355 CONCUSSION 37 0.0048
356 TRANSIENT ISCHAEMIC ATTACK 161 0.0048
357 JOINT RANGE OF MOTION DECREASED 64 0.0048
358 C-REACTIVE PROTEIN INCREASED 173 0.0048
359 URINARY INCONTINENCE 140 0.0047
360 ARTHROPOD BITE 35 0.0047
361 INTERSTITIAL LUNG DISEASE 228 0.0047
362 CEREBRAL INFARCTION 115 0.0047
363 ASTHENIA 1767 0.0047
364 GASTROOESOPHAGEAL REFLUX DISEASE 377 0.0047
365 EOSINOPHIL COUNT INCREASED 39 0.0047
366 OEDEMA 253 0.0047
367 LYMPHOMA 72 0.0047
368 LEUKOCYTOSIS 84 0.0046
369 VERTIGO 281 0.0046
370 PETECHIAE 48 0.0046
371 NODULE 60 0.0046
372 NASOPHARYNGITIS 837 0.0045
373 INJECTION SITE EXTRAVASATION 56 0.0045
374 JOINT SWELLING 546 0.0045
375 GINGIVAL PAIN 36 0.0045
376 DYSPHONIA 264 0.0045
377 LUNG DISORDER 221 0.0045
378 CARDIAC FAILURE ACUTE 30 0.0045
379 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 235 0.0045
380 INFLAMMATION 232 0.0045
381 EAR DISCOMFORT 46 0.0045
382 SKIN EXFOLIATION 378 0.0045
383 MUSCULOSKELETAL PAIN 234 0.0045
384 FACIAL PARALYSIS 38 0.0045
385 MYOCARDITIS 51 0.0044
386 SECOND PRIMARY MALIGNANCY 37 0.0044
387 ANAL INCONTINENCE 40 0.0044
388 WEIGHT DECREASED 1241 0.0044
389 PSEUDOMONAS INFECTION 38 0.0044
390 PULMONARY OEDEMA 198 0.0044
391 ECONOMIC PROBLEM 67 0.0044
392 HEART RATE INCREASED 438 0.0044
393 DISORIENTATION 175 0.0044
394 BRONCHOSPASM 63 0.0044
395 VITAMIN D DEFICIENCY 43 0.0044
396 HEPATIC STEATOSIS 82 0.0044
397 INFLUENZA LIKE ILLNESS 361 0.0044
398 PERIPHERAL SWELLING 675 0.0044
399 PULMONARY FIBROSIS 84 0.0044
400 MOVEMENT DISORDER 140 0.0044
401 INCONTINENCE 46 0.0043
402 INFUSION RELATED REACTION 288 0.0043
403 NAIL DISORDER 38 0.0043
404 POLYNEUROPATHY 52 0.0043
405 STATUS EPILEPTICUS 49 0.0043
406 MIDDLE INSOMNIA 81 0.0043
407 FLATULENCE 245 0.0043
408 EPISTAXIS 323 0.0043
409 RHEUMATOID ARTHRITIS 490 0.0043
410 ABDOMINAL PAIN 1003 0.0043
411 GLAUCOMA 83 0.0043
412 IMMUNOSUPPRESSION 38 0.0043
413 NASAL CONGESTION 253 0.0043
414 PRODUCT ADMINISTRATION ERROR 87 0.0043
415 HAEMOGLOBIN DECREASED 442 0.0043
416 URINARY TRACT INFECTION 733 0.0043
417 MASS 60 0.0043
418 ASPHYXIA 35 0.0043
419 SUPRAVENTRICULAR TACHYCARDIA 41 0.0043
420 ABDOMINAL PAIN LOWER 108 0.0043
421 SWELLING FACE 278 0.0043
422 OROPHARYNGEAL PAIN 395 0.0043
423 CARDIOMYOPATHY 63 0.0043
424 CARDIAC FAILURE 341 0.0042
425 SPINAL COMPRESSION FRACTURE 35 0.0042
426 THERMAL BURN 30 0.0042
427 PLEURAL EFFUSION 257 0.0042
428 FREQUENT BOWEL MOVEMENTS 114 0.0042
429 TENDON RUPTURE 52 0.0042
430 JOINT STIFFNESS 110 0.0042
431 BLOOD CHOLESTEROL INCREASED 195 0.0042
432 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 71 0.0042
433 GINGIVAL BLEEDING 57 0.0042
434 HAEMATOMA 108 0.0042
435 GASTROINTESTINAL HAEMORRHAGE 348 0.0042
436 INTERVERTEBRAL DISC PROTRUSION 91 0.0042
437 NASAL DISCOMFORT 33 0.0042
438 ASTHMA 470 0.0042
439 PERIPHERAL COLDNESS 57 0.0041
440 DYSPEPSIA 408 0.0041
441 HAEMATEMESIS 105 0.0041
442 DIZZINESS 2059 0.0041
443 THROAT IRRITATION 185 0.0041
444 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 32 0.0041
445 MICTURITION URGENCY 47 0.0041
446 SCHIZOPHRENIA 50 0.0041
447 DIVERTICULITIS 114 0.0041
448 PELVIC FRACTURE 32 0.0041
449 ALTERED STATE OF CONSCIOUSNESS 89 0.0041
450 MYALGIA 698 0.0041
451 ANAEMIA 783 0.0041
452 MALIGNANT MELANOMA 55 0.0041
453 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 197 0.0041
454 SWOLLEN TONGUE 128 0.0041
455 TENDON PAIN 31 0.0041
456 RHINITIS 33 0.0041
457 CEREBRAL HAEMORRHAGE 146 0.0041
458 HYPOKINESIA 59 0.0041
459 FAECES DISCOLOURED 88 0.0041
460 PHOTOSENSITIVITY REACTION 67 0.0041
461 ANAPHYLACTIC REACTION 224 0.0041
462 LIGAMENT SPRAIN 40 0.0040
463 CONTUSION 389 0.0040
464 CHEST PAIN 748 0.0040
465 LOSS OF CONSCIOUSNESS 517 0.0040
466 GAIT DISTURBANCE 771 0.0040
467 RASH PRURITIC 217 0.0040
468 BLOOD DISORDER 32 0.0040
469 SECRETION DISCHARGE 50 0.0040
470 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 38 0.0040
471 CONSTIPATION 868 0.0040
472 PAIN IN EXTREMITY 1172 0.0040
473 BLOOD GLUCOSE DECREASED 191 0.0040
474 ORAL PAIN 89 0.0040
475 MUCOSAL INFLAMMATION 104 0.0040
476 FOOT DEFORMITY 44 0.0040
477 DIPLOPIA 103 0.0040
478 BLOOD TRIGLYCERIDES INCREASED 70 0.0040
479 ELECTROCARDIOGRAM ABNORMAL 31 0.0039
480 COMA 188 0.0039
481 CHOKING 77 0.0039
482 DYSSTASIA 115 0.0039
483 RIB FRACTURE 81 0.0039
484 MACULAR DEGENERATION 47 0.0039
485 HYPERCHOLESTEROLAEMIA 38 0.0039
486 HALLUCINATION, VISUAL 83 0.0039
487 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 101 0.0039
488 THIRST 70 0.0039
489 OSTEOPOROSIS 161 0.0039
490 RESPIRATORY DISTRESS 108 0.0039
491 PARALYSIS 56 0.0039
492 RESTLESS LEGS SYNDROME 71 0.0039
493 BALANCE DISORDER 336 0.0039
494 HIP FRACTURE 125 0.0039
495 MEDICATION ERROR 216 0.0039
496 DIABETES MELLITUS 296 0.0039
497 MALAISE 1700 0.0039
498 ENCEPHALOPATHY 95 0.0039
499 HYPERTHYROIDISM 56 0.0039
500 CHOLECYSTITIS 46 0.0039
501 SEPTIC SHOCK 168 0.0039
502 MYOCLONUS 46 0.0039
503 HYPOTHERMIA 39 0.0038
504 LIVER FUNCTION TEST ABNORMAL 112 0.0038
505 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 34 0.0038
506 SPINAL PAIN 45 0.0038
507 DRY MOUTH 311 0.0038
508 NECK PAIN 214 0.0038
509 PSORIASIS 500 0.0038
510 SCIATICA 61 0.0038
511 HYPOTHYROIDISM 122 0.0038
512 PAIN IN JAW 108 0.0038
513 TOOTH FRACTURE 42 0.0038
514 METASTASES TO LUNG 44 0.0038
515 BLOOD THYROID STIMULATING HORMONE INCREASED 35 0.0038
516 CLOSTRIDIUM DIFFICILE INFECTION 83 0.0038
517 CONTRAINDICATED PRODUCT ADMINISTERED 115 0.0038
518 ABNORMAL FAECES 31 0.0038
519 KIDNEY INFECTION 74 0.0038
520 EYE HAEMORRHAGE 50 0.0037
521 PULMONARY HYPERTENSION 78 0.0037
522 TYPE 2 DIABETES MELLITUS 126 0.0037
523 WHITE BLOOD CELL COUNT INCREASED 143 0.0037
524 COVID-19 PNEUMONIA 44 0.0037
525 DRUG ERUPTION 66 0.0037
526 DEMENTIA 104 0.0037
527 PERICARDIAL EFFUSION 86 0.0037
528 INCREASED APPETITE 71 0.0037
529 CARPAL TUNNEL SYNDROME 52 0.0037
530 NEUTROPHIL COUNT INCREASED 38 0.0037
531 NEURALGIA 90 0.0037
532 INCREASED TENDENCY TO BRUISE 34 0.0037
533 MUSCULOSKELETAL STIFFNESS 323 0.0037
534 GLYCOSYLATED HAEMOGLOBIN INCREASED 93 0.0037
535 IRRITABLE BOWEL SYNDROME 79 0.0037
536 DIARRHOEA 2369 0.0037
537 ORAL DISCOMFORT 51 0.0037
538 SKIN CANCER 79 0.0037
539 EYE INFLAMMATION 35 0.0037
540 DIABETIC KETOACIDOSIS 88 0.0037
541 COAGULOPATHY 61 0.0037
542 SMALL INTESTINAL OBSTRUCTION 45 0.0037
543 LIMB DISCOMFORT 113 0.0036
544 DECREASED APPETITE 848 0.0036
545 WOUND 102 0.0036
546 BLOOD CALCIUM INCREASED 32 0.0036
547 AGEUSIA 91 0.0036
548 BACK PAIN 847 0.0036
549 DYSPNOEA 2058 0.0036
550 PNEUMONIA 1176 0.0036
551 BONE DISORDER 66 0.0036
552 TOXIC EPIDERMAL NECROLYSIS 55 0.0036
553 ACUTE RESPIRATORY DISTRESS SYNDROME 64 0.0036
554 COLITIS 137 0.0036
555 SYNOVITIS 65 0.0036
556 JOINT INJURY 77 0.0036
557 THROMBOCYTOPENIA 403 0.0036
558 SCRATCH 38 0.0036
559 ABDOMINAL DISCOMFORT 604 0.0036
560 LETHARGY 207 0.0036
561 ANXIETY 1023 0.0036
562 MYOCARDIAL INFARCTION 627 0.0036
563 PARKINSONISM 35 0.0036
564 ERECTILE DYSFUNCTION 92 0.0036
565 ABSCESS 57 0.0036
566 TINNITUS 164 0.0036
567 FEELING JITTERY 68 0.0036
568 PNEUMONITIS 97 0.0036
569 IMPAIRED WORK ABILITY 76 0.0036
570 HAEMOPTYSIS 99 0.0035
571 SLEEP DISORDER 250 0.0035
572 HYPOPHAGIA 90 0.0035
573 LUNG INFILTRATION 31 0.0035
574 BURNING SENSATION 246 0.0035
575 FEELING HOT 215 0.0035
576 BACK DISORDER 57 0.0035
577 DRUG LEVEL INCREASED 58 0.0035
578 BLOOD ALKALINE PHOSPHATASE INCREASED 87 0.0035
579 THYROID DISORDER 54 0.0035
580 POOR QUALITY SLEEP 75 0.0035
581 LIP SWELLING 116 0.0035
582 FOOT FRACTURE 66 0.0035
583 DEAFNESS 91 0.0035
584 OESOPHAGITIS 38 0.0035
585 INTESTINAL OBSTRUCTION 131 0.0035
586 GENERALISED OEDEMA 43 0.0035
587 MUSCLE ATROPHY 44 0.0035
588 FACIAL PAIN 31 0.0035
589 BLOOD CALCIUM DECREASED 39 0.0035
590 CYST 43 0.0035
591 HYPOXIA 122 0.0035
592 RED BLOOD CELL COUNT DECREASED 99 0.0035
593 COLD SWEAT 61 0.0035
594 PYREXIA 1195 0.0035
595 SINUS TACHYCARDIA 49 0.0034
596 PRODUCT PRESCRIBING ERROR 82 0.0034
597 ARTHRALGIA 1431 0.0034
598 ORAL HERPES 67 0.0034
599 GENERAL PHYSICAL HEALTH DETERIORATION 397 0.0034
600 BLOOD COUNT ABNORMAL 52 0.0034
601 HERPES ZOSTER 197 0.0034
602 PRURITUS GENERALISED 74 0.0034
603 METASTASES TO LIVER 60 0.0034
604 PARAESTHESIA ORAL 49 0.0034
605 CONJUNCTIVITIS 63 0.0034
606 EAR PAIN 66 0.0034
607 EXOSTOSIS 31 0.0034
608 VOMITING 1595 0.0034
609 LOCALISED INFECTION 82 0.0034
610 FUNGAL INFECTION 113 0.0034
611 RASH ERYTHEMATOUS 162 0.0034
612 PANCYTOPENIA 189 0.0034
613 PALLOR 92 0.0034
614 PHARYNGEAL OEDEMA 52 0.0034
615 WOUND INFECTION 37 0.0034
616 EMPHYSEMA 34 0.0034
617 FLUID RETENTION 171 0.0034
618 BLOOD GLUCOSE ABNORMAL 62 0.0034
619 ABDOMINAL DISTENSION 349 0.0033
620 ORAL CANDIDIASIS 44 0.0033
621 ACTIVITIES OF DAILY LIVING IMPAIRED 66 0.0033
622 RENAL DISORDER 155 0.0033
623 NIGHTMARE 115 0.0033
624 HELICOBACTER INFECTION 34 0.0033
625 GALLBLADDER DISORDER 59 0.0033
626 DISTURBANCE IN ATTENTION 178 0.0033
627 FATIGUE 2569 0.0033
628 NEPHROLITHIASIS 151 0.0033
629 COLON CANCER 49 0.0033
630 TOOTH DISORDER 73 0.0033
631 HAEMORRHAGE INTRACRANIAL 49 0.0033
632 NERVOUSNESS 171 0.0033
633 PNEUMONIA BACTERIAL 30 0.0033
634 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 76 0.0033
635 ERUCTATION 63 0.0033
636 TASTE DISORDER 66 0.0032
637 SKIN ULCER 84 0.0032
638 SPEECH DISORDER 170 0.0032
639 SCAB 37 0.0032
640 SKIN DISORDER 108 0.0032
641 WEIGHT INCREASED 725 0.0032
642 RASH MACULAR 113 0.0032
643 BLOOD GLUCOSE INCREASED 608 0.0032
644 ACUTE RESPIRATORY FAILURE 62 0.0032
645 DRUG INTOLERANCE 310 0.0032
646 CHILLS 375 0.0032
647 FLUSHING 325 0.0032
648 HEAD INJURY 101 0.0032
649 BLINDNESS UNILATERAL 45 0.0032
650 LACERATION 30 0.0032
651 DRUG-INDUCED LIVER INJURY 100 0.0032
652 SARS-COV-2 TEST POSITIVE 42 0.0032
653 NAUSEA 2514 0.0032
654 DELIRIUM 110 0.0032
655 METASTASES TO BONE 52 0.0032
656 ASPARTATE AMINOTRANSFERASE INCREASED 168 0.0032
657 VIRAL INFECTION 105 0.0032
658 CHOLECYSTECTOMY 36 0.0031
659 NERVE INJURY 35 0.0031
660 GASTRIC DISORDER 108 0.0031
661 ALANINE AMINOTRANSFERASE INCREASED 193 0.0031
662 HEADACHE 1966 0.0031
663 DYSKINESIA 127 0.0031
664 MULTI-ORGAN FAILURE 54 0.0031
665 SKIN REACTION 44 0.0031
666 PANCREATITIS 165 0.0031
667 ECZEMA 163 0.0031
668 HYPOAESTHESIA 466 0.0031
669 THROAT TIGHTNESS 84 0.0031
670 ABDOMINAL PAIN UPPER 638 0.0031
671 FEELING COLD 86 0.0031
672 VISION BLURRED 424 0.0031
673 PNEUMOCYSTIS JIROVECII PNEUMONIA 31 0.0031
674 PHARMACEUTICAL PRODUCT COMPLAINT 80 0.0031
675 MUSCLE SPASMS 564 0.0031
676 EYE DISORDER 101 0.0031
677 PHARYNGITIS 38 0.0031
678 CHOLELITHIASIS 100 0.0030
679 EYE PAIN 172 0.0030
680 EAR INFECTION 81 0.0030
681 SCAR 52 0.0030
682 PRURITUS 1167 0.0030
683 DISCOMFORT 185 0.0030
684 INTENTIONAL PRODUCT USE ISSUE 265 0.0030
685 PRODUCT SUBSTITUTION ISSUE 174 0.0030
686 POST PROCEDURAL COMPLICATION 58 0.0030
687 ULCER 48 0.0030
688 HYPERHIDROSIS 388 0.0030
689 FEAR 81 0.0030
690 BLOOD GLUCOSE FLUCTUATION 33 0.0030
691 BLISTER 169 0.0030
692 HOT FLUSH 226 0.0030
693 HYPERBILIRUBINAEMIA 31 0.0030
694 GLOSSODYNIA 67 0.0030
695 THYROID CANCER 36 0.0030
696 PULMONARY EMBOLISM 283 0.0030
697 SOMNOLENCE 599 0.0030
698 TENDERNESS 31 0.0030
699 ANKLE FRACTURE 46 0.0030
700 VENTRICULAR TACHYCARDIA 49 0.0030
701 BEDRIDDEN 39 0.0030
702 GASTRIC HAEMORRHAGE 34 0.0030
703 ABASIA 73 0.0030
704 PRODUCT TASTE ABNORMAL 40 0.0030
705 MOBILITY DECREASED 212 0.0029
706 PARAESTHESIA 464 0.0029
707 MOUTH ULCERATION 62 0.0029
708 TACHYCARDIA 261 0.0029
709 NEUROPATHY PERIPHERAL 279 0.0029
710 ANHEDONIA 77 0.0029
711 HEPATIC CIRRHOSIS 55 0.0029
712 POST PROCEDURAL HAEMORRHAGE 34 0.0029
713 PERICARDITIS 49 0.0029
714 SKIN LESION 80 0.0029
715 RETCHING 62 0.0029
716 TEMPERATURE INTOLERANCE 30 0.0029
717 IMPAIRED DRIVING ABILITY 33 0.0029
718 CANDIDA INFECTION 49 0.0029
719 COVID-19 508 0.0029
720 IMPAIRED HEALING 95 0.0029
721 DEPRESSED LEVEL OF CONSCIOUSNESS 114 0.0029
722 APATHY 42 0.0029
723 FULL BLOOD COUNT DECREASED 58 0.0029
724 WEIGHT FLUCTUATION 30 0.0029
725 ATAXIA 34 0.0029
726 INSOMNIA 763 0.0029
727 TREMOR 474 0.0029
728 LACRIMATION INCREASED 86 0.0028
729 MUSCLE TIGHTNESS 46 0.0028
730 EYE INFECTION 32 0.0028
731 OSTEOPENIA 43 0.0028
732 UVEITIS 38 0.0028
733 SWELLING 262 0.0028
734 CHROMATURIA 63 0.0028
735 HYPOAESTHESIA ORAL 42 0.0028
736 DERMATITIS ALLERGIC 35 0.0028
737 DECREASED ACTIVITY 30 0.0028
738 BACTERAEMIA 33 0.0028
739 CONDITION AGGRAVATED 844 0.0028
740 NIGHT SWEATS 89 0.0028
741 SEPSIS 308 0.0028
742 HEPATIC ENZYME INCREASED 188 0.0028
743 RASH 1201 0.0028
744 EYELID OEDEMA 32 0.0028
745 DIALYSIS 39 0.0027
746 HALLUCINATION 207 0.0027
747 BODY TEMPERATURE INCREASED 56 0.0027
748 MULTIPLE FRACTURES 45 0.0027
749 TOOTH INFECTION 36 0.0027
750 BURSITIS 33 0.0027
751 INTERNAL HAEMORRHAGE 31 0.0027
752 HEAD DISCOMFORT 48 0.0027
753 INTENTIONAL PRODUCT MISUSE 235 0.0027
754 THERAPEUTIC RESPONSE SHORTENED 89 0.0027
755 PNEUMONIA ASPIRATION 67 0.0027
756 VISUAL ACUITY REDUCED 89 0.0027
757 ACCIDENTAL OVERDOSE 98 0.0027
758 CARDIAC ARREST 221 0.0027
759 LUNG NEOPLASM MALIGNANT 110 0.0027
760 BLOOD BILIRUBIN INCREASED 72 0.0027
761 RESPIRATORY FAILURE 193 0.0026
762 DELUSION 41 0.0026
763 ACUTE HEPATIC FAILURE 36 0.0026
764 BLOOD TEST ABNORMAL 37 0.0026
765 THINKING ABNORMAL 49 0.0026
766 FEELING ABNORMAL 625 0.0026
767 CARDIAC DISORDER 243 0.0026
768 UNRESPONSIVE TO STIMULI 67 0.0026
769 PAIN 1591 0.0026
770 URTICARIA 432 0.0026
771 ERYTHEMA 529 0.0026
772 RESPIRATORY TRACT INFECTION 67 0.0026
773 HAIR COLOUR CHANGES 32 0.0026
774 DRY EYE 128 0.0026
775 STEVENS-JOHNSON SYNDROME 57 0.0026
776 TRANSAMINASES INCREASED 57 0.0026
777 UPPER RESPIRATORY TRACT INFECTION 118 0.0026
778 DEPRESSED MOOD 135 0.0026
779 POISONING 32 0.0025
780 CYANOSIS 40 0.0025
781 RESPIRATORY DISORDER 76 0.0025
782 STOMATITIS 154 0.0025
783 THROMBOSIS 204 0.0025
784 EYE SWELLING 94 0.0025
785 LOCAL SWELLING 44 0.0025
786 TENDONITIS 39 0.0025
787 HEPATIC FUNCTION ABNORMAL 94 0.0025
788 PERITONITIS 52 0.0025
789 LUNG INFECTION 39 0.0025
790 UPPER LIMB FRACTURE 50 0.0025
791 APHONIA 35 0.0025
792 EXTRAPYRAMIDAL DISORDER 62 0.0025
793 OSTEOMYELITIS 45 0.0025
794 LIVER DISORDER 110 0.0025
795 FLUID OVERLOAD 36 0.0025
796 QUALITY OF LIFE DECREASED 33 0.0025
797 PNEUMOTHORAX 39 0.0025
798 SKIN DISCOLOURATION 113 0.0025
799 HYPERSENSITIVITY 456 0.0025
800 FEMUR FRACTURE 76 0.0025
801 EPILEPSY 75 0.0025
802 HYPERSOMNIA 70 0.0024
803 ROAD TRAFFIC ACCIDENT 102 0.0024
804 ILLNESS 251 0.0024
805 LYMPHOCYTE COUNT DECREASED 43 0.0024
806 AGITATION 178 0.0024
807 DEEP VEIN THROMBOSIS 157 0.0024
808 FEBRILE NEUTROPENIA 160 0.0024
809 WHITE BLOOD CELL COUNT DECREASED 261 0.0024
810 BONE PAIN 141 0.0024
811 BLOOD LACTATE DEHYDROGENASE INCREASED 38 0.0024
812 SEROTONIN SYNDROME 46 0.0024
813 DERMATITIS 50 0.0024
814 HERNIA 46 0.0024
815 AMNESIA 154 0.0024
816 MULTIPLE ORGAN DYSFUNCTION SYNDROME 67 0.0024
817 PLATELET COUNT DECREASED 251 0.0024
818 HIP ARTHROPLASTY 36 0.0023
819 IMMUNODEFICIENCY 35 0.0023
820 INTRAOCULAR PRESSURE INCREASED 30 0.0023
821 SPINAL FRACTURE 47 0.0023
822 FIBROMYALGIA 57 0.0023
823 DEPRESSION 530 0.0023
824 HEPATIC FAILURE 70 0.0023
825 ABNORMAL DREAMS 64 0.0023
826 LYMPHADENOPATHY 82 0.0023
827 FACE OEDEMA 39 0.0023
828 OCULAR HYPERAEMIA 109 0.0023
829 GENERALISED TONIC-CLONIC SEIZURE 38 0.0023
830 DISEASE RECURRENCE 108 0.0023
831 RESTLESSNESS 83 0.0023
832 TOOTHACHE 41 0.0023
833 BACTERIAL INFECTION 42 0.0022
834 CARDIOVASCULAR DISORDER 57 0.0022
835 STAPHYLOCOCCAL INFECTION 74 0.0022
836 HAIR TEXTURE ABNORMAL 30 0.0022
837 PHOTOPHOBIA 42 0.0022
838 NEUTROPENIA 303 0.0022
839 MYELODYSPLASTIC SYNDROME 32 0.0022
840 INTENTIONAL DOSE OMISSION 63 0.0022
841 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 398 0.0022
842 IMPAIRED GASTRIC EMPTYING 30 0.0022
843 COGNITIVE DISORDER 102 0.0022
844 EYE IRRITATION 125 0.0022
845 FEEDING DISORDER 44 0.0022
846 GASTROENTERITIS VIRAL 39 0.0022
847 TOXICITY TO VARIOUS AGENTS 364 0.0022
848 RESPIRATORY ARREST 59 0.0021
849 ANAPHYLACTIC SHOCK 55 0.0021
850 LIVER INJURY 52 0.0021
851 COLITIS ULCERATIVE 93 0.0021
852 PREMATURE DELIVERY 33 0.0021
853 ALOPECIA 407 0.0021
854 PRODUCT AVAILABILITY ISSUE 47 0.0021
855 SENSORY DISTURBANCE 33 0.0021
856 INJURY 144 0.0020
857 RASH GENERALISED 53 0.0020
858 PANCREATIC CARCINOMA 59 0.0020
859 ILL-DEFINED DISORDER 124 0.0020
860 CRYING 74 0.0020
861 VISUAL IMPAIRMENT 252 0.0020
862 INFECTION 294 0.0020
863 OFF LABEL USE 1773 0.0020
864 PSORIATIC ARTHROPATHY 82 0.0020
865 HALLUCINATION, AUDITORY 32 0.0020
866 THERAPEUTIC RESPONSE DECREASED 122 0.0020
867 OVERDOSE 432 0.0020
868 THERAPY NON-RESPONDER 90 0.0020
869 MEMORY IMPAIRMENT 275 0.0020
870 EYE PRURITUS 67 0.0020
871 HEPATOTOXICITY 44 0.0020
872 BLINDNESS 80 0.0020
873 PROCEDURAL PAIN 54 0.0019
874 SKIN FISSURES 38 0.0019
875 NEUROTOXICITY 34 0.0019
876 ASCITES 57 0.0019
877 UNEVALUABLE EVENT 146 0.0019
878 PRESCRIBED OVERDOSE 37 0.0019
879 DRUG ABUSE 159 0.0019
880 MENTAL STATUS CHANGES 53 0.0019
881 CYTOKINE RELEASE SYNDROME 38 0.0019
882 CONVULSION 108 0.0019
883 RASH PAPULAR 42 0.0019
884 BONE MARROW FAILURE 38 0.0019
885 ANGER 63 0.0019
886 LEUKOPENIA 93 0.0019
887 DRUG ADMINISTRATION ERROR 56 0.0018
888 LOWER LIMB FRACTURE 35 0.0018
889 TREATMENT NONCOMPLIANCE 99 0.0018
890 PRESCRIBED UNDERDOSE 36 0.0018
891 GAIT INABILITY 60 0.0018
892 PREMATURE BABY 54 0.0018
893 NEEDLE ISSUE 52 0.0018
894 SUICIDE ATTEMPT 108 0.0018
895 MENTAL IMPAIRMENT 43 0.0018
896 LIVER FUNCTION TEST INCREASED 38 0.0018
897 HAEMORRHAGE 185 0.0018
898 INTENTIONAL OVERDOSE 112 0.0017
899 FRACTURE 33 0.0017
900 NERVOUS SYSTEM DISORDER 54 0.0017
901 LABORATORY TEST ABNORMAL 51 0.0017
902 MOOD ALTERED 47 0.0017
903 DRUG PRESCRIBING ERROR 33 0.0017
904 NEUTROPHIL COUNT DECREASED 70 0.0017
905 DRUG INEFFECTIVE 2237 0.0017
906 THERAPEUTIC RESPONSE UNEXPECTED 76 0.0017
907 MUSCULOSKELETAL DISORDER 32 0.0017
908 WRONG TECHNIQUE IN DRUG USAGE PROCESS 61 0.0017
909 MIGRAINE 160 0.0017
910 OSTEONECROSIS OF JAW 41 0.0017
911 DRY SKIN 221 0.0017
912 DYSTONIA 32 0.0016
913 EMOTIONAL DISORDER 50 0.0016
914 PANIC ATTACK 59 0.0016
915 NEOPLASM PROGRESSION 56 0.0016
916 ADVERSE EVENT 148 0.0016
917 HYPOACUSIS 69 0.0016
918 SUICIDAL IDEATION 145 0.0016
919 INCORRECT PRODUCT ADMINISTRATION DURATION 34 0.0016
920 PRODUCT DOSE OMISSION ISSUE 459 0.0016
921 PRODUCT USE ISSUE 293 0.0016
922 ABNORMAL BEHAVIOUR 61 0.0015
923 PSYCHOTIC DISORDER 45 0.0015
924 DISABILITY 30 0.0015
925 DISEASE PROGRESSION 178 0.0015
926 PLASMA CELL MYELOMA 58 0.0015
927 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 104 0.0015
928 NEOPLASM MALIGNANT 97 0.0015
929 TOOTH LOSS 30 0.0014
930 AGGRESSION 71 0.0014
931 TARDIVE DYSKINESIA 40 0.0014
932 SEIZURE 163 0.0014
933 THERAPY CESSATION 72 0.0014
934 SURGERY 82 0.0014
935 MALIGNANT NEOPLASM PROGRESSION 142 0.0014
936 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 98 0.0014
937 SKIN IRRITATION 63 0.0014
938 PRODUCT DOSE OMISSION 89 0.0014
939 MENTAL DISORDER 59 0.0014
940 PRODUCT USE IN UNAPPROVED INDICATION 336 0.0014
941 DRUG EFFECT DECREASED 73 0.0014
942 MUSCLE TWITCHING 31 0.0013
943 THERAPY INTERRUPTED 94 0.0013
944 INJECTION SITE MASS 48 0.0013
945 THERAPEUTIC PRODUCT EFFECT DECREASED 56 0.0012
946 BONE DENSITY DECREASED 39 0.0012
947 PAIN OF SKIN 33 0.0012
948 MOOD SWINGS 39 0.0012
949 PRODUCT QUALITY ISSUE 166 0.0012
950 ADVERSE DRUG REACTION 109 0.0012
951 INCORRECT DOSE ADMINISTERED 276 0.0012
952 EMOTIONAL DISTRESS 144 0.0012
953 PRODUCT DOSE OMISSION IN ERROR 33 0.0012
954 EXPOSURE VIA SKIN CONTACT 30 0.0012
955 OSTEONECROSIS 38 0.0012
956 DRUG EFFECT INCOMPLETE 42 0.0012
957 IRRITABILITY 69 0.0011
958 INJECTION SITE BRUISING 91 0.0011
959 INJECTION SITE HAEMORRHAGE 90 0.0011
960 SKIN BURNING SENSATION 80 0.0011
961 UNDERDOSE 81 0.0011
962 INJECTION SITE PAIN 340 0.0011
963 MULTIPLE SCLEROSIS 53 0.0011
964 WITHDRAWAL SYNDROME 46 0.0011
965 INJECTION SITE PRURITUS 73 0.0011
966 BREAST CANCER 99 0.0011
967 INJECTION SITE ERYTHEMA 130 0.0010
968 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 35 0.0010
969 HOSPITALISATION 155 0.0010
970 RENAL CANCER 48 0.0010
971 ACNE 76 0.0010
972 DRUG DOSE OMISSION 160 0.0010
973 SYSTEMIC LUPUS ERYTHEMATOSUS 34 0.0010
974 DEATH 825 0.0010
975 PROSTATE CANCER 77 0.0010
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 193 0.0010
977 EXPIRED PRODUCT ADMINISTERED 30 0.0009
978 COMPLETED SUICIDE 72 0.0009
979 DEVICE MALFUNCTION 60 0.0009
980 EXPOSURE DURING PREGNANCY 51 0.0008
981 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 44 0.0008
982 MATERNAL EXPOSURE DURING PREGNANCY 67 0.0008
983 TREATMENT FAILURE 62 0.0007
984 INJECTION SITE REACTION 51 0.0007
985 INJECTION SITE SWELLING 56 0.0007
986 MULTIPLE SCLEROSIS RELAPSE 50 0.0007
987 DERMATITIS ATOPIC 38 0.0007
988 BLADDER CANCER 41 0.0007
989 DEVICE ISSUE 60 0.0007
990 ACCIDENTAL EXPOSURE TO PRODUCT 63 0.0006
991 DRUG WITHDRAWAL SYNDROME 50 0.0006
992 FOETAL EXPOSURE DURING PREGNANCY 43 0.0005
993 DRUG DEPENDENCE 82 0.0005
994 NO ADVERSE EVENT 92 0.0005